Kaniwa, Nahoko <br/><br/>
[Utilization of Genomic Biomarkers for Post-marketing Safety of Drugs].  [electronic resource] 

 -  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan  2015 
 - 671-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1347-5231 
<br/><br/><label>Standard No.: </label>10.1248/yakushi.14-00230-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents<br/>Biomarkers, Pharmacological--blood<br/>Camptothecin--analogs & derivatives<br/>Deoxycytidine--analogs & derivatives<br/>Drug Eruptions--etiology<br/>Drug-Related Side Effects and Adverse Reactions<br/>Genomics<br/>Glucuronosyltransferase--blood<br/>HLA Antigens--blood<br/>Humans<br/>International Cooperation<br/>Irinotecan<br/>Japan<br/>Pharmacogenetics<br/>Precision Medicine--trends<br/>Prodrugs<br/>Product Surveillance, Postmarketing<br/>Gemcitabine